Therefore, Roseburia, which belongs to butyrate-producing bacteria and alleviates experimental colitis pathology by inducing anti-inflammatory responses (such as Roseburia intestinalis) [28, 29], might play an essential role on the bioconversion variation of GCK between healthy subjects and CRC patients. The gene discussed is GCK; the disease is colitis.